首页> 外文会议>2011 international conference on bioinformatics and biomedical technology >Construction of Lentivira Expression Vector of siRNA Specific for DEC1 and Identification of Its Efficiency in Human Gastric Carcinoma Cell MGC803
【24h】

Construction of Lentivira Expression Vector of siRNA Specific for DEC1 and Identification of Its Efficiency in Human Gastric Carcinoma Cell MGC803

机译:DEC1特异的siRNA Lentivira表达载体的构建及其在人胃癌细胞MGC803中的效率鉴定

获取原文
获取原文并翻译 | 示例

摘要

AIM To construct the small interfering RNA ( s iRNA ) lentiviral expression vector specific for human DEC1 gene and to evaluate its activity of inhibiting the DEC1 expression in human gastric carcinoma cell MGC803. Methods DEC1 siRNA template DNA sequences were designed and synthesized. The annealed siRNA template was inserted into pGCSIL-PUR shRNA Cloning and Expression vector. The recombinant plasmid (pGCSIL-PUR-DECl)was transformed into DHSa cell and identified by PCR and DNA sequencing. A lentiviral expression vector containing enhanced green fluorescence protein (GFP) and DEC1 small interfering RNA (siRNA) (Lenti-DEClsi), or the control siRNA (Lenti-NC) gene was constructed. We observed the rate of siRNA transfection by using fluorescence microscope.At 72h after transfection,the silencing efficiency to DEC1 gene expression were analyzed by RT-PCR and Western blot. RESULTS DNA sequencing showed Targeting siRNA oligonucleotides were correctly inserted into the pGCSIL-PUR shRNA Cloning and Expression vector without base mutation. Four days after transfection with Lenti-DEClsi (MOI: 100), the expression of the DEC1 mRNA and protein in cells significantly decreased compared with the Lenti-NC. CONCLUSION It is the first time that we silenced the DEC1 gene byhe small interfering RNA ( s iRNA ) lentiviral expression vector specific for DEC1 in an gastric adenocarcinoma cell MGC803, which lays the basis for its application in the treatment of gastric carcinoma.
机译:目的构建人DEC1基因特异的小干扰RNA慢病毒表达载体,评价其在人胃癌细胞MGC803中抑制DEC1表达的活性。方法设计并合成DEC1 siRNA模板DNA序列。将退火的siRNA模板插入到pGCSIL-PUR shRNA克隆和表达载体中。将重组质粒(pGCSIL-PUR-DEC1)转化到DHSa细胞中,并通过PCR和DNA测序鉴定。构建了包含增强的绿色荧光蛋白(GFP)和DEC1小干扰RNA(siRNA)(Lenti-DEClsi)或对照siRNA(Lenti-NC)基因的慢病毒表达载体。用荧光显微镜观察siRNA的转染率。转染后72h,采用RT-PCR和Western blot方法分析其对DEC1基因表达的沉默效率。结果DNA测序表明,靶向siRNA寡核苷酸已正确插入pGCSIL-PUR shRNA克隆和表达载体中,而没有碱基突变。 Lenti-DEClsi(MOI:100)转染后四天,与Lenti-NC相比,细胞中DEC1 mRNA和蛋白的表达显着降低。结论这是我们首次通过特异性针对DEC1的小干扰RNA(s iRNA)慢病毒表达载体沉默DEC1基因在胃腺癌细胞MGC803中的应用,这为其在胃癌治疗中的应用奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号